Related Experiment Video
Updated: Jun 24, 2025

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
Published on: January 15, 2010
Modeling Parkinson's Disease in Primates
Erwan Bezard1,2,3, Margaux Teil4, Marie-Laure Arotcarena4
1Université de Bordeaux, Centre National de la Recherche Scientifique (CNRS), IMN, UMR 5293, F-33000 Bordeaux, France erwan.bezard@u-bordeaux.fr.
Abstract:
Decades of research have identified the pathological and pathophysiological hallmarks of Parkinson's disease (PD): profound deficit in brain dopamine and other monoamines, pathological α-synuclein aggregation, synaptic and neuronal network dysfunction, aberrant proteostasis, altered energy homeostasis, inflammation, and neuronal cell death. The purpose of this contribution is to present the phenocopy aspect, pathogenic, and etiologic nonhuman primate (NHP) models of PD to readers with limited prior knowledge of PD so that they are ready to start working on PD. How NHPs, the closest species to man on which we can model diseases, contribute to the knowledge progress and how these models represent an invaluable translational step in therapeutic development are highlighted.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
EPS and iPS Cells in Disease Research

